Mengshi Liao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mengshi Liao has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Meng Wang
3 shared publications- Yuhua Fan
Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
3 shared publications Anil M Tuladhar
2 shared publications- Hao Li
Department of Neurology, Donders Center for Medical Neurosciences Radboud University Medical Center Nijmegen The Netherlands
2 shared publications Wenli Zhou
2 shared publicationsFubing Ouyang
Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 20 October 2026
- Published by Elsevier in Cerebral Circulation - Cognition and Behavior
- Vol. 11
Cortical microinfarcts are associated with thalamic subregional volume and cognitive impairment in small vessel disease
- 20 October 2026
- Published by Elsevier in Cerebral Circulation - Cognition and Behavior
- Vol. 11
Open AccessCortical microinfarcts are associated with thalamic subregional volume and cognitive impairment in small vessel disease
- 3 September 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (4) , 1780-1792
Disruptions of deep medullary veins and MRI indices of glymphatic function in cerebral small vessel disease
Background: Disruptions of deep medullary veins (DMV) have been associated with the radiological severity and cognitive impairment observed in cerebral small vessel disease (SVD). Glymphatic dysfunction may serve as a potential mechanism underlying these associations. Objective: We aimed to clarify the associations between DMV disruptions, MRI indices previously hypothesized as related to glymphatic function, white matter hyperintensities (WMH), and cognitive impairment in SVD. Methods: This cross-sectional study included 133 SVD participants. DMV disruptions were visually rated on susceptibility-weighted imaging (SWI). Five MRI indices related to glymphatic function were measured: the diffusion tensor imaging along the perivascular space (DTI-ALPS), free water (FW) fraction, choroid plexus (Cp) volumes, perivascular spaces in basal ganglia (BG-PVS) and white matter (WM-PVS). Results: Higher DMV scores were associated with higher WMH volumes (β = 0.55, p < 0.001) and lower Montreal Cognitive Assessment (MoCA) scores (β = −0.24, p = 0.003). Higher DMV scores were correlated with lower DTI-ALPS values, higher FW fraction, higher volumes in Cp, BG-PVS, and WM-PVS (all p < 0.001). DTI-ALPS values and BG-PVS volumes mediated the associations between DMV scores and WMH volumes, with only BG-PVS volumes mediating the associations between DMV scores and MoCA scores. Conclusions: Our results suggested that DMV disruptions contribute to WMH burden and cognitive impairment in SVD. This effect could be mediated by MRI markers indicative of glymphatic dysfunction, particularly the enlargement of BG-PVS.
- 3 September 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (4) , 1780-1792
Disruptions of deep medullary veins and MRI indices of glymphatic function in cerebral small vessel disease
Background: Disruptions of deep medullary veins (DMV) have been associated with the radiological severity and cognitive impairment observed in cerebral small vessel disease (SVD). Glymphatic dysfunction may serve as a potential mechanism underlying these associations. Objective: We aimed to clarify the associations between DMV disruptions, MRI indices previously hypothesized as related to glymphatic function, white matter hyperintensities (WMH), and cognitive impairment in SVD. Methods: This cross-sectional study included 133 SVD participants. DMV disruptions were visually rated on susceptibility-weighted imaging (SWI). Five MRI indices related to glymphatic function were measured: the diffusion tensor imaging along the perivascular space (DTI-ALPS), free water (FW) fraction, choroid plexus (Cp) volumes, perivascular spaces in basal ganglia (BG-PVS) and white matter (WM-PVS). Results: Higher DMV scores were associated with higher WMH volumes (β = 0.55, p < 0.001) and lower Montreal Cognitive Assessment (MoCA) scores (β = −0.24, p = 0.003). Higher DMV scores were correlated with lower DTI-ALPS values, higher FW fraction, higher volumes in Cp, BG-PVS, and WM-PVS (all p < 0.001). DTI-ALPS values and BG-PVS volumes mediated the associations between DMV scores and WMH volumes, with only BG-PVS volumes mediating the associations between DMV scores and MoCA scores. Conclusions: Our results suggested that DMV disruptions contribute to WMH burden and cognitive impairment in SVD. This effect could be mediated by MRI markers indicative of glymphatic dysfunction, particularly the enlargement of BG-PVS.
- Open Access
- 20 January 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 350, 600-607
Discontinuity of deep medullary veins in SWI is associated with deep white matter hyperintensity volume and cognitive impairment in cerebral small vessel disease
- 20 January 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 350, 600-607
Open AccessDiscontinuity of deep medullary veins in SWI is associated with deep white matter hyperintensity volume and cognitive impairment in cerebral small vessel disease
- 21 November 2023
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 44 (4) , 477-490
Enhanced angiogenesis in the thalamus induced by a novel TSPO ligand ameliorates cognitive deficits after focal cortical infarction
Neuronal loss in the ipsilateral thalamus after focal cortical infarction participates in post-stroke cognitive deficits, and enhanced angiogenesis in the thalamus is expected to reduce neuronal damage. We hypothesize that novel translocator protein (TSPO) ligand, 2-Cl-MGV-1, can promote angiogenesis, attenuate neuronal loss in the thalamus, and ameliorate post-stroke cognitive deficits. Cortical infarction was induced by distal middle cerebral artery occlusion (dMCAO) in stroke-prone renovascular hypertensive rats. 2-Cl-MGV-1 or dimethyl sulfoxide was administered 24 h after dMCAO and then for 6 or 13 days. Spatial learning and memory were assessed using the Morris water maze. Neuronal loss, TSPO expression, angiogenesis, and intrinsic pathway were determined by immunofluorescence and immunoblotting 7 and 14 days after dMCAO. Cortical infarction caused post-stroke cognitive deficits and secondary neuronal loss with gliosis in the ipsilateral thalamus within 14 days of dMCAO. Increased angiogenesis and elevated expression of vascular TSPO were detected in the ipsilateral thalamus, and treatment with 2-Cl-MGV-1 enhanced angiogenesis by stimulating the PI3K-AKT-mTOR pathway. The effects of 2-Cl-MGV-1 on angiogenesis coincided with reduced neuronal loss in the thalamus and contributed to improvements in post-stroke cognitive deficits. Our findings suggest that 2-Cl-MGV-1 stimulates angiogenesis, ameliorates neuronal loss in the thalamus, and improves post-stroke cognitive deficits.
- 21 November 2023
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 44 (4) , 477-490
Enhanced angiogenesis in the thalamus induced by a novel TSPO ligand ameliorates cognitive deficits after focal cortical infarction
Neuronal loss in the ipsilateral thalamus after focal cortical infarction participates in post-stroke cognitive deficits, and enhanced angiogenesis in the thalamus is expected to reduce neuronal damage. We hypothesize that novel translocator protein (TSPO) ligand, 2-Cl-MGV-1, can promote angiogenesis, attenuate neuronal loss in the thalamus, and ameliorate post-stroke cognitive deficits. Cortical infarction was induced by distal middle cerebral artery occlusion (dMCAO) in stroke-prone renovascular hypertensive rats. 2-Cl-MGV-1 or dimethyl sulfoxide was administered 24 h after dMCAO and then for 6 or 13 days. Spatial learning and memory were assessed using the Morris water maze. Neuronal loss, TSPO expression, angiogenesis, and intrinsic pathway were determined by immunofluorescence and immunoblotting 7 and 14 days after dMCAO. Cortical infarction caused post-stroke cognitive deficits and secondary neuronal loss with gliosis in the ipsilateral thalamus within 14 days of dMCAO. Increased angiogenesis and elevated expression of vascular TSPO were detected in the ipsilateral thalamus, and treatment with 2-Cl-MGV-1 enhanced angiogenesis by stimulating the PI3K-AKT-mTOR pathway. The effects of 2-Cl-MGV-1 on angiogenesis coincided with reduced neuronal loss in the thalamus and contributed to improvements in post-stroke cognitive deficits. Our findings suggest that 2-Cl-MGV-1 stimulates angiogenesis, ameliorates neuronal loss in the thalamus, and improves post-stroke cognitive deficits.